Metraipolis › archive › dc_bf1566ec6eb3

Potential heterogeneity of epcoritamab associated adverse events in demographics and dosing regimens — Europe PMC PMID:42564023

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42564023
DOI
10.3389/fmed.2026.1832550
License (as archived)
solo-consultazione
Archived
2026-10-08T05:10:42.973Z
SHA-256 of the archived text
c9a6e565e4287e1b7fd131f8bb8cf0868a1597ff1a2094cb096032197fea2484
Stable URL of this page
https://metraipolis.com/documento/dc_bf1566ec6eb3

How to cite

Potential heterogeneity of epcoritamab associated adverse events in demographics and dosing regimens — Europe PMC PMID:42564023 — Europe PMC (en), https://europepmc.org/article/MED/42564023 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf1566ec6eb3 (Metraipolis archive dc_bf1566ec6eb3, sha256 c9a6e565e4287e1b7fd131f8bb8cf0868a1597ff1a2094cb096032197fea2484)
BibTeX
@misc{dcbf1566ec6eb3,
  title = {Potential heterogeneity of epcoritamab associated adverse events in demographics and dosing regimens — Europe PMC PMID:42564023},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42564023},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf1566ec6eb3; sha256 c9a6e565e4287e1b7fd131f8bb8cf0868a1597ff1a2094cb096032197fea2484},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42564023. Agents can read the archived copy with the MCP tool read_document.